Skip to content

Drug interactions

Efavirenz + Sunitinib

Severity: Major

Efavirenz and Sunitinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both can prolong the QT interval, and efavirenz may lower sunitinib exposure by inducing CYP3A4. This could add to arrhythmia risk while reducing anticancer effect.

What this interaction means in plain words

Efavirenz and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Efavirenz belongs to Anti Virals; Sunitinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT prolongation plus efavirenz induction of CYP3A4 metabolism of sunitinib.

What to do

Prefer a non-inducing antiretroviral. If combined, monitor ECG and electrolytes, and consider a sunitinib dose increase as directed in labeling for CYP3A4 inducers.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Sunitinib?

MediHelp rates the interaction as major. Efavirenz and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both can prolong the QT interval, and efavirenz may lower sunitinib exposure by inducing CYP3A4. This could add to arrhythmia risk while reducing anticancer effect.

How serious is the interaction between Efavirenz and Sunitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing antiretroviral. If combined, monitor ECG and electrolytes, and consider a sunitinib dose increase as directed in labeling for CYP3A4 inducers.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in